Media Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org.
An LLS representative will respond as soon as possible.
The Leukemia & Lymphoma Society Applauds FDA Approval of Blinatumomab To Treat Patients with Acute Lymphoblastic Leukemia
For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org
White Plains, NY (December 3, 2014) - Today's U.S. Food and Drug Administration (FDA) approval of blinatumomab to treat patients with an uncommon form of acute lymphoblastic leukemia is a significant advance for patients with this form of bloo...
Research Funded by The Leukemia & Lymphoma Society Among Highlights at Annual American Society of Hematology
For Immediate Release
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (December 1, 2014) - Many researchers funded by The Leukemia & Lymphoma Society (LLS) will be among those presenting innovative directions in blood cancer research at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition in San Francisco in early December. T...
Burlington Stores and The Leukemia & Lymphoma Society: A Powerful Partnership that Helps to Save Lives
LLS Contact:
Kristin Hoose
914-821-8973
Kristin.Hoose@lls.org
Burlington Stores Contact:
Bari Kurzman
212-522-2121
BariK@mbooth.com
White Plains, NY (November 19, 2014) - For the 13th consecutive year, Burlington Stores and The Leukemia & Lymphoma Society's (LLS) Light The Night® partnered to shin...
The Leukemia & Lymphoma Society Awards $15.6 Million to Help Advance Research from Lab to Clinic
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (Oct. 29, 2014) -- The Leukemia & Lymphoma Society (LLS) is awarding $15.6 million in academic grants to 26 scientists who have proposed innovative laboratory research that shows promise in leading to new treatments for blood cancer patients.
The funds are being awarded through LLS's Translational Re...
The Leukemia & Lymphoma Society Launches New Initiative to Halt the Progression of Myeloid Blood Cancers
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (October 28, 2014) - The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ultimately, stop progression of certain types of blood cancers from early-stage malignancies to much more lethal states of disease.
The types of early-stage blood cancers the...
The Leukemia & Lymphoma Society Announces Recipients of Grants Supporting New Drug Discovery
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (Oct. 21, 2014) - For the second year, The Leukemia & Lymphoma Society (LLS) will award funding to leading scientists and researchers who show promise in developing new drug therapies through the Screen to Lead Program.
The collaborative program aims to support academic laboratories pursuing research directed towar...
The Leukemia & Lymphoma Society Awards Six New Research Grants Focused on Innovative New Ideas
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (October 20, 2014) - Six academic investigators will receive grants from The Leukemia & Lymphoma Society (LLS) to support innovative ideas that that have the potential to take research in a new direction and fundamentally impact the future of blood cancer diagnosis and treatment.
The second-year grant program...
Immunotherapy Study Funded by The Leukemia & Lymphoma Society Demonstrates Remarkable Results in Patients with Acute Lymphoblastic Leukemia
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (October 16, 2014) - Funding from The Leukemia & Lymphoma Society (LLS) over the past 22 years helped advance a study published today in the New England Journal of Medicine showing that 90 percent of children and adults with acute lymphoblastic leukemia (ALL) achieved complete remission after receiving an investigatio...